Testing effectiveness (Phase 2)Study completedNCT01592045What this trial is testingCh14.18 Pharmacokinetic Study in High-risk NeuroblastomaWho this might be right forNeuroblastoma United Therapeutics 28
Not applicableActive Not RecruitingNCT05388370What this trial is testingPASS of Paediatric Patients Initiating SelumetinibWho this might be right forNeurofibromatosis Type 1 AstraZeneca 124
Early research (Phase 1)Ended earlyNCT00054405What this trial is testingInterleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent NeuroblastomaWho this might be right forRecurrent Neuroblastoma National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00357396What this trial is testingBusulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's TumorsWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 10
Not applicableUnknownNCT05684835What this trial is testingRadiographic Prediction of the Nerve Origin of Neck Peripheral Nerve Sheath TumorsWho this might be right forPeripheral Nerve Sheath TumorsSchwannoma of Neck National Cheng-Kung University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00436852What this trial is testingABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous TreatmentWho this might be right forDisseminated NeuroblastomaRecurrent Neuroblastoma Children's Oncology Group 92
Not applicableStudy completedNCT03542097What this trial is testingAssessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and IrinotecanWho this might be right forEwing Sarcoma Family of Tumors Istituto Ortopedico Rizzoli 82
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01868490What this trial is testingThe Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK CellsWho this might be right forCholangiocarcinomaNeuroblastoma Siriraj Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06255210What this trial is testingEfficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)Who this might be right forOlfactory Neuroblastoma Hongmeng Yu 25
Testing effectiveness (Phase 2)Study completedNCT00911560What this trial is testingBivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk NeuroblastomaWho this might be right forNeuroblastoma Memorial Sloan Kettering Cancer Center 374
Not applicableStudy completedNCT04879160What this trial is testingSystematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical TrialWho this might be right forNeurofibromatosis 1 National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT00003023What this trial is testingMonoclonal Antibody A1G4 Plus BCG in Treating Patients With CancerWho this might be right forNeuroblastomaSarcoma Memorial Sloan Kettering Cancer Center 24
Not applicableLooking for participantsNCT06844461What this trial is testingQuality of Life and Decisional Regret in Patients Affected by Acoustic NeuromaWho this might be right forQuality of Life OutcomesAcoustic Schwannoma IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Not applicableLooking for participantsNCT06574698What this trial is testingAdding Of Naxitamb In Induction Therapy For High Risk NeuroblastomaWho this might be right forNeuroblastomaGD2 Antibody (Naxitamab) Guangzhou Women and Children's Medical Center 64
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Not applicableStudy completedNCT01109238What this trial is testingA Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent NeuroblastomaWho this might be right forRefractory NeuroblastomaRelapsed Neuroblastoma Giselle Sholler 5
Testing effectiveness (Phase 2)WithdrawnNCT00874315What this trial is testingAllogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.Who this might be right forNeuroblastoma Nationwide Children's Hospital
Testing effectiveness (Phase 2)Study completedNCT00070525What this trial is testingTipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem GliomaWho this might be right forChildhood High-grade Cerebral AstrocytomaChildhood OligodendrogliomaRecurrent Childhood Brain Stem Glioma+5 more National Cancer Institute (NCI) 90
Early research (Phase 1)UnknownNCT00002647What this trial is testingPhotodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMetastatic Cancer Medical College of Wisconsin 24
Not applicableStudy completedNCT00293384What this trial is testingAprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Barbara Ann Karmanos Cancer Institute 40